Posted in | News | Iron Ore | Coal | Mining Business

Rio Tinto Looks to Acquire Riversdale Mining

Rio Tinto is about to make a bid for Riversdale Mining at $15 per share. This would be a $3.5 billion takeover bid made by the British company. There is a likelihood of the move attracting a counter bid from the Brazilian mining giant Vale.

The attraction is Riversdale Mining owned coal assets in Africa. The company which is listed in Australia has some high quality coal deposits in Mozambique. A 24 % stake in Riversdale Mining is held by Tata Steel. Many of its mines are jointly owned with the Indian conglomerate.

While both the parties involved refused to comment on the possible takeover bid the market has been speculating over it for a while. Rio Tinto has already announced previously that it was looking at a number of acquisitions in the low single digit billion price range, and Riversdale fits the bill.

The Riversdale Mining Benga Licence saw its Coal Resources upgraded to 4 billion tonnes and Coal reserves increased to 502 million tonnes in May this year. The proved Resources are at 346 million tonnes while the probable are at 156 million tonnes. A Feasibility Study has begun to confirm the economic viability of this expanded mining operation.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 18). Rio Tinto Looks to Acquire Riversdale Mining. AZoMining. Retrieved on May 19, 2024 from

  • MLA

    Chai, Cameron. "Rio Tinto Looks to Acquire Riversdale Mining". AZoMining. 19 May 2024. <>.

  • Chicago

    Chai, Cameron. "Rio Tinto Looks to Acquire Riversdale Mining". AZoMining. (accessed May 19, 2024).

  • Harvard

    Chai, Cameron. 2019. Rio Tinto Looks to Acquire Riversdale Mining. AZoMining, viewed 19 May 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.